1-3 of 3
Joshua Epstein, PhD
Close
Sort by
Journal Articles

The Benefit of FVIII Measurement: Tailored Treatment with Obi-1, a Recombinant Porcine Sequence Factor VIII, in Subjects with Acquired Hemophilia a

Abiola Oladapo, PhD, Joshua Epstein, PhD, Aaron Novack, PhD, Heinrich D. Farin, MD
Journal: Blood
Blood (2014) 124 (21): 3509.
https://doi.org/10.1182/blood.V124.21.3509.3509
Published: 2014
Journal Articles

Exomic microRNA Profiling of Bone Marrow Aspirate Plasma and Comparison with mRNA Profiles Used in the Clinical Management of Multiple Myeloma

Ryan K Van Laar, PhD, Rachel Flinchum, MSc, Brown Nathan, MSc, Joseph Ramsey, MSc, John Shaughnessy, PhD, Joshua Epstein, PhD, Christoph Heuck, MD, Bart Barlogie, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5681.
https://doi.org/10.1182/blood.V124.21.5681.5681
Published: 2014
Journal Articles

Changes in the Expression of Proteasome Genes in Tumor Cells Following Short-Term Proteasome Inhibitor Therapy Predicts Survival in Multiple Myeloma Treated with Bortezomib-Containing Multi-Agent Chemotherapy

John D. Shaughnessy, Jr., PhD, Pingping Qu, MD, Ricky Edmondson, PhD, Damir Herman, PhD, Yiming Zhou, PhD, Erming Tian, Frits van Rhee, MD, PhD, Mauricio Pineda-Roman, MD, PhD, Yazan Alsayed, Elias Anaissie, Ya-wei Qiang, Joshua Epstein, PhD, Shmuel Yaccoby, PhD, David Williams, Fenghuang Zhan, PhD, Owen Stephens, Antje Hoering, PhD, John Crowley, PhD, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 733.
https://doi.org/10.1182/blood.V112.11.733.733
Published: 2008